The Society for Healthcare Epidemiology of America (SHEA) has released a new consensus statement providing pediatric-specific recommendations for the infection prevention and control of Candida auris (also referred to as Candidozyma auris), a multidrug-resistant fungal pathogen associated with health care-associated infections and outbreaks worldwide. The research is published in the journal Antimicrobial Stewardship & Healthcare Epidemiology. Read more ›
Learn More About New to Medical Device Sales Here: Read more ›
‘Groundbreaking’ Potential Lupus Cure Sends Patients into Remission, Allowing Dreams to Be Fulfilled
A genetic therapy that’s already revolutionized cancer treatment has now sent five patients of lupus into remission, allowing one to fulfill her dreams of skiing. The uncurable autoimmune disorder lupus affects 1.5 million Americans, but a trial of CAR T-cell therapy for lupus recently concluded in the UK shows that the disease’s permanence may be […] The post appeared first on . Read more ›
Healthcare cybersecurity services are essential for protecting sensitive patient information, hospital systems, and digital health records… Read more ›
Highlands Oncology recently announced that CEO Jeff Hunnicutt concluded his service with the organization on June 19, marking the end of an eight-year tenure that saw significant growth and expansion across Northwest Arkansas. During Hunnicutt’s leadership, Highlands Oncology doubled in… The post appeared first on <a href=" Read more ›
China is rapidly catching up with the US on biotech capabilities, a survey found. US industry and academic leaders said that while America still had an advantage in talent, handing frontier research to industry, and getting it to market, China leads in manufacturing and clinical development, and the two are on par at scientific discovery. […] The post appeared first on <a href=" Read more ›
submitted by China has become a major source of new medicines and clinical research, reshaping the global pharmaceutical-industry landscape, Pfizer Chief International Commercial Officer Alexandre de Germay said at an event hosted by industry lobby group the European Federation of Pharmaceutical Industries and Associations (EFPIA). “Today, 40% of all clinical studies in oncology in the world are in China,” de Germay said. “The volume of innovation that is coming out of biotech in China i... Read more ›
...well as the Diabetic Neuropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United ... accounts for the highest prevalent cases in 2025 and is expected to increase at a significant CAGR by 2036. According to the... Read more ›
The security of hospitals is a growing issue as healthcare providers need to safeguard patient information, medical records, and the… Read more ›
The HHS (FDA, NIH, ARPA-H and related agencies) is moving to speed clinical trials in what they are calling Operation TrialBlazer (kudos on the pun). The motivator, of course, is China: China has made biotechnology a strategic national priority, systematically expanding its clinical research infrastructure with government backing, streamlined regulatory pathways, and sustained investment. In […] The post appeared first on . Related Stories Read more ›
Compounded medications currently represent an estimated 1% to 3% of all prescriptions written in the United States, according to a recent 2025-2026 report issued by the Alliance for Pharmacy Compounding.“There’s a good chance you know someone who has benefited — or whose pet has benefited — from a compounded drug,” read the report, which was released in March.According to experts who spoke with Healio — as well as the FDA — compound pharmacies, and the compounded drugs they offer, can fill an... Read more ›
HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spinal disorders, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the VersaLift™ Expandable Interbody System, a Micro Invasive™ solution for TLIF and PLIF procedures featuring a low 6mm starting height. Read more ›
Hangzhou Qihan Biotech announced that its off-the-shelf, dual-target allogeneic CAR-T therapy QT-019B has received Regenerative Medicine Advanced Therapy and Breakthrough Therapy designations from the U.S. FDA. The awards follow a Fast Track designation granted in November 2025, placing QT-019B among a small group of cell therapies that hold all three of the FDA’s top expedited […] The post appeared first on <a href=" Read more ›
In silico models in oncology, neurology, and epidemiology: systems-level and multiscale perspectives
Computational medicine uses mathematical modelling, high-performance computing, and the availability of large-scale biomedical data to study multiscale complex diseases. This review synthesises recent developments in in silico oncology, neurology, and epidemiology, highlighting their shared methodological foundations in systems theory and complex networks. We discuss how combining mechanistic approaches with machine learning integrates heterogeneous data. Finally, we identify translation barr... Read more ›
States that have banned abortion are suing to stop mailing of abortion pills over state lines. But the telehealth providers say no matter the outcome, they can adapt, and so will their patients. Read more ›
Dallas Innovates, Every Day: Here's what's new + next in North Texas. Dallas-based Susan G. Komen, the world’s leading breast cancer organization, recently awarded $15.4 million in grants to breast cancer researchers on the journey to unlocking the cures for all breast cancers. Covering some of the most promising areas of research, the funded projects include the use of AI for better health outcomes and vaccines that could target the most aggressive and deadliest forms of breast cancer.… The ... Read more ›
Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to see another trial. Read more ›
A major pharmaceutical manufacturer is suing the Arkansas Board of Pharmacy, seeking to stop implementation of a state law barring drug manufactures from restricting the availability of medication to a limited distribution network of out-of-state pharmacies. Read more ›
The global Advanced Passive Components Market, valued at a robust level in 2023, is on a trajectory of significant expansion, projected to reach substantially higher levels by 2031. This growth, re… Read more ›
Anya Singh is an Editorial Cartoonist and medical student who draws from her experiences in medicine to comment on health care, medical education and the systems that shape patient care. She can be reached at anyas@umich.edu. The post appeared first on . Read more ›